Related Experiment Video
Updated: May 29, 2025
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Pulmonary function tests in infants following SARS-CoV-2 infection
Avigdor Hevroni1, Talya Benenson-Weinberg2, Laurice S Boursheh2
1Department of Pediatrics and the Pediatric Pulmonology and CF Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Department of Paediatrics, Assuta Medical Center, Ashdod, Israel.
Introduction:
The clinical spectrum of SARS-CoV-2 infection is well-established. However, understanding its long-term implications, especially in infants, remains limited. We aimed to evaluate pulmonary function tests in infants (iPFT) several months after a documented SARS-CoV-2 infection.
Methods:
An observational case-control study was performed. iPFT results in infants with persistent respiratory complaints several months after a SARS-CoV-2 infection were compared to a registry of patients assessed at our center between 2008 and 2019 using the Mann-Whitney U and Fisher's exact tests. Excluded from the study were infants with chronic diseases and extreme prematurity.
Results:
iPFT data from sixteen infants with respiratory complaints and a history of SARS-CoV-2 infection and 475 controls were evaluated in the study. The median time between the SARS-CoV-2 infection and iPFT evaluation was 5.5 months (IQR = 2.8-8.0). There were no differences between cases and controls in clinical characteristics and reason for iPFT evaluation. iPFT results showed no significant differences between cases and controls in lung volumes, compliance, or resistance. Expiratory airflow limitation was observed in both groups, with better low lung volume flows in the SARS-CoV-2 group. Categorization according to iPFT physiologic alteration and bronchodilator responsiveness were similar in the two groups.
Conclusion:
This study provides the first comprehensive iPFT data in infants following a SARS-CoV-2 infection. The findings suggest that SARS-CoV-2 infection does not cause unique long-term effects on pulmonary function in infants with chronic respiratory symptoms. Further studies in larger cohorts, particularly in infants with severe acute SARS-CoV-2 infection, are warranted to validate these findings.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:30Pneumonia III: Complications and Assessment
01:17Pulmonary Cycle: Exhalation
01:47Lung Capacity
01:20Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History